1. Home
  2. ASST vs OGN Comparison

ASST vs OGN Comparison

Compare ASST & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Asset Entities Inc. Class B

ASST

Asset Entities Inc. Class B

N/A

Current Price

$14.67

Market Cap

3.1B

Sector

Technology

ML Signal

N/A

Logo Organon & Co.

OGN

Organon & Co.

N/A

Current Price

$13.90

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASST
OGN
Founded
2020
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.6B
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
ASST
OGN
Price
$14.67
$13.90
Analyst Decision
Strong Buy
Hold
Analyst Count
5
4
Target Price
★ $40.60
$10.33
AVG Volume (30 Days)
★ 5.8M
2.4M
Earning Date
12-01-2026
10-30-2026
Dividend Yield
N/A
★ 0.58%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 1.56
Revenue
$633,489.00
★ $6,216,000,000.00
Revenue This Year
$94.12
N/A
Revenue Next Year
N/A
$2.07
P/E Ratio
★ N/A
$8.92
Revenue Growth
★ 128.67
N/A
52 Week Low
$0.49
$5.69
52 Week High
$31.95
$13.94

Technical Indicators

Market Signals
Indicator
ASST
OGN
Relative Strength Index (RSI) 26.46 63.29
Support Level $14.32 $13.76
Resistance Level $18.40 N/A
Average True Range (ATR) 1.89 0.04
MACD -0.66 0.00
Stochastic Oscillator 0.59 80.56

Price Performance

Historical Comparison
ASST
OGN

About ASST Asset Entities Inc. Class B

Strive Inc is a structured finance company and institutional asset manager focused on disciplined capital allocation and long term value creation. The company has adopted bitcoin as its hurdle rate for capital deployment because of its fiduciary duty to maximize long-term value for stockholders, and compounding purchasing power over time. It operates in two reportable operating segments: the Asset Management segment, which provides investment advisory services and the Corporate & Other segment, which includes the company's bitcoin treasury operations. The majority of the revenue is derived from the Asset Management segment.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: